Seattle, WA, United States of America

Blaze Bioscience, Inc.

USPTO Granted Patents = 8

% Expired Patents = 12.5


Trademarks = 5

Forward Citations = 5

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Natalie Winblade Nairn (7 out of 11 patents)

silverMedal Julia E Novak (6 out of 56 patents)

bronzeMedal Dennis M Miller (5 out of 5 patents)

4.  Scott R Presnell (4 out of 129 patents)

5.  Mark R Stroud (4 out of 11 patents)

6.  Claudia Jochheim (3 out of 3 patents)

7.  Stacey J Hansen (3 out of 3 patents)

8.  Roland K Strong (2 out of 8 patents)

9.  Christopher Mehlin (2 out of 29 patents)

10.  Andrew David Strand (2 out of 2 patents)

11.  Emily June Girard (2 out of 2 patents)

12.  Colin Correnti (2 out of 10 patents)

13.  James M Olson (2 out of 18 patents)

14.  Valorie R Wiss (2 out of 2 patents)

15.  Kelly Byrnes-Blake (2 out of 2 patents)


8 patents:

Company Overview
Blaze Bioscience, Inc. is a biotechnology company focused on developing targeted cancer therapies. Their proprietary Tumor Paint technology aims to improve surgical outcomes by enabling more precise visualization of cancer cells during surgery. By illuminating tumor cells, surgeons can more accurately remove cancerous tissue while sparing healthy cells. Blaze Bioscience is committed to advancing the field of oncology and improving patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#245 in Seattle, WA

#826 in Washington

#35,941 in US

Seattle, WA (US)
Seattle, WA, United States of America
Forward Citations = 5

17 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Blaze Bioscience, Inc.. Retrieved from https://idiyas.com/company/blaze-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…